mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.04 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.088 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |